Serum hepcidin levels and iron metabolism in obese children with and without fatty liver: Case-control study

European Journal of Pediatrics

Volumn 173, Issue 7, 2014, Pages 947-951

  Demircioğlu, Fatih ^a   Görünmez, Gökhan ^a   Dağıstan, Emine ^a   Göksügür, Sevil Bilir ^a   Bekdaş, Mervan ^a   Tosun, Mehmet ^a   Kızıldağ, Betül ^a   Kısmet, Erol ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Children; Fatty liver; Hepcidin; Iron metabolism; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; FERRITIN; HEPCIDIN; IRON; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE CONTROL STUDY; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON METABOLISM; LEUKOCYTE COUNT; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; IRON METABOLISM DISORDER;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; FEMALE; HEPCIDINS; HUMANS; IRON METABOLISM DISORDERS; LIPIDS; LIVER FUNCTION TESTS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PEDIATRIC OBESITY;

EID: 84903821106     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-014-2268-8     Document Type: Article

References (31)

1. Amato A, Santoro N, Calabro P, Grandone A, Swinkels DW, Perrone L, del Giudice EM (2010) Effect of body mass index reduction on serum hepcidin levels and iron status in obese children. Int J Obes (Lond) 34:1772-1774
2. Baynes RD (1996) Assessment of iron status. Clin Biochem 29:209-215
3. Cepeda-Lopez AC, Osendarp SJ, Melse-Boonstra A, Aeberli I, Gonzalez-Salazar F, Feskens E, Villalpando S, Zimmermann MB (2011) Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake. Am J Clin Nutr 93:975-983
4. Chang JS, Chang CC, Chien EY, Lin SS, Cheng-Shiuan T, Bai CH, Chao KC (2013) Association between interleukin 1beta and interleukin 10 concentrations: a cross-sectional study in young adolescents in Taiwan. BMC Pediatr 13:123
5. Dao MC, Meydani SN (2013) Iron biology, immunology, aging, and obesity: four fields connected by the small peptide hormone hepcidin. Adv Nutr 4:602-617
6. del Giudice EM, Santoro N, Amato A, Brienza C, Calabro P, Wiegerinck ET, Cirillo G, Tartaglione N, Grandone A, Swinkels DW, Perrone L (2009) Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 94:5102-5107
7. Dunn LL, Suryo Rahmanto Y, Richardson DR (2007) Iron uptake and metabolism in the new millennium. Trends Cell Biol 17:93-100 (Pubitemid 46199183)
8. Fleming RE, Sly WS (2001) Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A 98:8160-8162 (Pubitemid 32678004)
9. Ganz T (2005) Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol 18:171-182
10. Haluzik M, Parizkova J, Haluzik MM (2004) Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res 53:123-129 (Pubitemid 38525115)
11. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556 (Pubitemid 38766330)
12. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) CDC growth charts for the United States: methods and development. Vital Health Stat 11:1-190
13. Lee SH, Jeong SH, Park YS, Hwang JH, Kim JW, Kim N, Lee DH (2010) Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease. Korean J Hepatol 16:288-294
14. Mehta K, Van Thiel DH, Shah N, Mobarhan S (2002) Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 60:289-293 (Pubitemid 35025794)
15. Mendler MH, Turlin B, Moirand R, Jouanolle AM, Sapey T, Guyader D, Le Gall JY, Brissot P, David V, Deugnier Y (1999) Insulin resistance-associated hepatic iron overload. Gastroenterology 117:1155-1163 (Pubitemid 29512675)
16. Menzie CM, Yanoff LB, Denkinger BI, McHugh T, Sebring NG, Calis KA, Yanovski JA (2008) Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 108:145-148 (Pubitemid 350301976)
17. Moafi A, Rahgozar S, Ghias M, Ahar EV, Borumand A, Sabbaghi A, Sameti A, Hashemi M (2011) A study on body mass index, blood pressure, and red blood cell indices in new entering students of the University of Isfahan. Int J Prev Med 2:280-285
18. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M (2004) Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 114:104-108 (Pubitemid 38857573)
19. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T (2003) Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-2463 (Pubitemid 36857598)
20. Poskitt EM (1995) The fat child. In: Brook CGD (ed) Clinical paediatric endocrinology, 3rd edn. Blackwell, London, pp 210-233
21. Quinn SF, Gosink BB (1985) Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol 145:753-755 (Pubitemid 16216509)
22. Sanad M, Osman M, Gharib A (2011) Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: a case control study. Ital J Pediatr 37:34
23. Seltzer CC, Mayer J (1963) Serum iron and iron-binding capacity in adolescents. Comparison of obese and nonobese subjects. Am J Clin Nutr 13:354-361
24. Senates E, Yilmaz Y, Colak Y, Ozturk O, Altunoz ME, Kurt R, Ozkara S, Aksaray S, Tuncer I, Ovunc AO (2011) Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease. Metab Syndr Relat Disord 9:287-290
25. Tilg H, Ulmer H, Kaser A, Weiss G(2002) Role of IL-10 for induction of anemia during inflammation. J Immunol 169:2204-2209 (Pubitemid 34857689)
26. Trayhurn P, Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347-355 (Pubitemid 40277057)
27. Turlin B, Mendler MH, Moirand R, Guyader D, Guillygomarc'h A, Deugnier Y (2001) Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 116:263-270 (Pubitemid 33044332)
28. van der Aa MP, Fazeli Farsani S, Kromwijk LA, de Boer A, Knibbe CA, van der Vorst MM (2013) How to screen obese children at risk for type 2 diabetes mellitus? Clin Pediatr (Phila). doi:10.1177/0009922813509480
29. Vuppalanchi R, Troutt JS, Konrad RJ, Ghabril M, Saxena R, Bell LN, Kowdley KV, Chalasani N (2013) Serum hepcidin levels are associated with obesity but not liver disease. Obesity (Silver Spring). doi:10.1002/oby.20403
30. Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT, Yanovski JA (2007) Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 31:1412-1419 (Pubitemid 47339930)
31. Zhang X, Rovin BH (2013) Beyond anemia: hepcidin, monocytes and inflammation. Biol Chem 394:231-238